Company profile: Illumina
1.1 - Company Overview
Company description
- Provider of next-generation sequencing platforms (NovaSeq, NextSeq, MiSeq) for genomic research and clinical applications; microarray kits and scanners for genotyping and epigenetics; library preparation kits for DNA and RNA; and DRAGEN bioinformatics for rapid genomic data analysis and management to analyze genetic variation and function.
Products and services
- Next-Generation Sequencing (NGS) Platforms: Illumina architects a scalable range—NovaSeq, NextSeq, MiSeq—built for genomic research and clinical applications, enabling high-throughput sequencing across varied project sizes
- Illumina DRAGEN Bioinformatics: Illumina delivers an accelerated platform for rapid genomic data analysis, offering secondary analysis pipelines and unified data management to support sequencing workflows
- Library Preparation Kits: Illumina supplies high-throughput-capable kits engineered to prepare DNA and RNA samples for sequencing, accommodating diverse applications and throughput requirements.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Illumina
Nanocyl
HQ: Belgium
Website
- Description: Provider of carbon nanotubes (CNTs) and formulated CNT products that improve ESD/electrical conductivity, mechanical reinforcement, thermal dissipation and eco-friendly fouling release. Products: NC7000 industrial multiwall CNTs; PLASTICYL CNT masterbatches in thermoplastics; AQUACYL waterborne dispersions for coatings and energy storage; ORGACYL solventborne dispersions; EPOCYL epoxy concentrates; THERMOCYL silicone-based flame retardant coatings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanocyl company profile →
Vironova
HQ: Sweden
Website
- Description: Provider of solutions for sub-visible particle analysis, offering products and services used in the development of particles for vaccines, drug delivery and gene therapy, as well as viral safety testing and material quality control; founded in 2005 from interdisciplinary research at the Karolinska Institute in Stockholm, Sweden.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vironova company profile →
Cerahelix
HQ: United States
Website
- Description: Provider of ceramic picofiltration products for high-purity, low-pressure water purification. Its bio-derived solutions use patented DNA template technology to form sub-nanometer pores in ceramic, enabling very minute particle filtration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cerahelix company profile →
Medicom Innovation Partner
HQ: Denmark
Website
- Description: Provider of device strategy, product design and development services, serving the drug delivery device sector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicom Innovation Partner company profile →
NanoSight
HQ: United Kingdom
Website
- Description: Provider of instruments for optical detection and real-time analysis of sub-micron particles, including NanoSight Pro, a machine learning nanoparticle analyzer enabling automated particle tracking and analysis of 10 to 1000 nm with fluorescence detection, and Smart Manager, a cloud-connected solution for continuous data analysis, improving data management and accessibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoSight company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Illumina
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Illumina
2.2 - Growth funds investing in similar companies to Illumina
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Illumina
4.2 - Public trading comparable groups for Illumina
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →